P Trunet

1.6k total citations
34 papers, 1.2k citations indexed

About

P Trunet is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, P Trunet has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in P Trunet's work include Estrogen and related hormone effects (13 papers), Respiratory Support and Mechanisms (3 papers) and Intensive Care Unit Cognitive Disorders (3 papers). P Trunet is often cited by papers focused on Estrogen and related hormone effects (13 papers), Respiratory Support and Mechanisms (3 papers) and Intensive Care Unit Cognitive Disorders (3 papers). P Trunet collaborates with scholars based in Switzerland, France and United Kingdom. P Trunet's co-authors include I E Smith, Mitch Dowsett, Timothy Iveson, H.A. Chaudri, Myfanwy Morgan, Lawrence Panasci, Robert Leonard, G. Gardin, P Dombernowsky and A. Gudgeon and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

P Trunet

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P Trunet Switzerland	15	779	409	392	247	145	34	1.2k
Katja Mitrunen Finland	14	466 0.6×	264 0.6×	193 0.5×	147 0.6×	58 0.4×	16	1.3k
Debora Macis Italy	16	226 0.3×	323 0.8×	223 0.6×	70 0.3×	63 0.4×	49	876
Gary Zirpoli United States	24	329 0.4×	785 1.9×	355 0.9×	122 0.5×	52 0.4×	74	1.8k
Olof Nyrén Sweden	12	95 0.1×	386 0.9×	174 0.4×	168 0.7×	111 0.8×	13	1.1k
Johanie Lépine Canada	13	258 0.3×	205 0.5×	56 0.1×	50 0.2×	100 0.7×	21	843
Barry Hoffman Canada	18	76 0.1×	545 1.3×	244 0.6×	127 0.5×	252 1.7×	30	1.5k
Clemens Schafmayer Germany	23	75 0.1×	605 1.5×	213 0.5×	405 1.6×	90 0.6×	61	1.8k
Stewart L. MacLeod United States	20	348 0.4×	237 0.6×	201 0.5×	86 0.3×	62 0.4×	39	1.3k
B. Levin United Kingdom	22	287 0.4×	116 0.3×	70 0.2×	60 0.2×	161 1.1×	49	1.5k
Manjinder S. Sandhu United Kingdom	17	185 0.2×	213 0.5×	169 0.4×	76 0.3×	325 2.2×	26	1.2k

Countries citing papers authored by P Trunet

Since Specialization

Citations

This map shows the geographic impact of P Trunet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Trunet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Trunet more than expected).

Fields of papers citing papers by P Trunet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Trunet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Trunet. The network helps show where P Trunet may publish in the future.

Co-authorship network of co-authors of P Trunet

This figure shows the co-authorship network connecting the top 25 collaborators of P Trunet. A scholar is included among the top collaborators of P Trunet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Trunet. P Trunet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sioufi, A., et al.. (1997). COMPARATIVE BIOAVAILABILITY OF LETROZOLE UNDER FED AND FASTING CONDITIONS IN 12 HEALTHY SUBJECTS AFTER A 2·5 MG SINGLE ORAL ADMINISTRATION. Biopharmaceutics & Drug Disposition. 18(6). 489–497. 65 indexed citations

Bisagni, Giancarlo, et al.. (1996). Letrozole, a new oral non-steroidal aromastase inhibitor in treating postmenopausal patients with advanced breast cancer. A pilot study. Annals of Oncology. 7(1). 99–102. 67 indexed citations

Smith, IE, Mitch Dowsett, P Trunet, et al.. (1996). Therapeutic effects of the aromatase inhibitor fadrozole hydrochloride in advanced breast cancer. British Journal of Cancer. 73(4). 539–542. 23 indexed citations

Dowsett, Mitch, John W. Moore, P Trunet, et al.. (1994). Endocrine changes with the aromatase inhibitor fadrozole hydrochloride in breast cancer. European Journal of Cancer. 30(10). 1453–1458. 36 indexed citations

Iveson, Timothy, et al.. (1993). Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in healthy postmenopausal women.. The Journal of Clinical Endocrinology & Metabolism. 77(2). 324–331. 66 indexed citations

Trunet, P, et al.. (1993). Open dose-finding study of a new potent and selective nonsteroidal aromatase inhibitor, CGS 20 267, in healthy male subjects.. The Journal of Clinical Endocrinology & Metabolism. 77(2). 319–323. 61 indexed citations

Bhatnagar, A.S., et al.. (1992). Inhibition of estrogen biosynthesis and its consequences on gonadotrophin secretion in the male. The Journal of Steroid Biochemistry and Molecular Biology. 41(3-8). 437–443. 48 indexed citations

Trunet, P, Paul S. Mueller, F Girard, et al.. (1992). The effects of fadrozole hydrochloride on aldosterone secretion in healthy male subjects.. The Journal of Clinical Endocrinology & Metabolism. 74(3). 571–576. 42 indexed citations

Hoeffken, Klaus, et al.. (1990). Original article: CGS 16949A, a new aromatase inhibitor in the treatment of breast cancer — A Phase I study. Annals of Oncology. 1(6). 421–426. 14 indexed citations

10.

Trunet, P, et al.. (1990). Phase I study in healthy male volunteers with the non-steroidal aromatase inhibitor CGS 20267. European Journal of Cancer and Clinical Oncology. 26(2). 173–173. 3 indexed citations

11.

Trunet, P. (1986). Pharmacovigilance industrielle Notification spontanée: recueil, enquête. La Revue de Médecine Interne. 7. 35–40. 1 indexed citations

12.

Trunet, P, Ivan T. Borda, Antoine Rouget, M Rapin, & F Lhoste. (1986). The role of drug-induced illness in admissions to an intensive care unit. Intensive Care Medicine. 12(1). 43–46. 18 indexed citations

13.

Brun‐Buisson, Christian, et al.. (1985). Haemolytic streptococcal gangrene and non-steroidal anti-inflammatory drugs.. BMJ. 290(6484). 1786.1–1786. 69 indexed citations

14.

Danan, Gaby, P Trunet, Jacques Bernuau, et al.. (1985). Pirprofen-induced fulminant hepatitis. Gastroenterology. 89(1). 210–213. 34 indexed citations

15.

Trunet, P, et al.. (1984). [Mechanical properties of the lung in paraquat-poisoned rats. Histopathologic correlates].. PubMed. 20(1). 25–30. 2 indexed citations

16.

Trunet, P, et al.. (1983). [Suppurating splenic infarction originating from endocarditis].. PubMed. 76(11). 1357–61. 1 indexed citations

17.

Trunet, P, J. R. Le Gall, F Lhoste, & M Rapin. (1982). Admissions to intensive care units for iatrogenic diseases.. PubMed. 73–84. 2 indexed citations

18.

Méllière, D, et al.. (1980). [Salmonella abdominal aortic aneurysm. One case undergoing fissuration and successfully treated surgically (author's transl)].. PubMed. 106(6). 419–23. 1 indexed citations

19.

Trunet, P, et al.. (1980). [Exposed intestinal fistulas in evisceration. Prevention and surgical treatment].. PubMed. 9(4). 291–2. 1 indexed citations

20.

Carlet, Jean, et al.. (1979). IS AN INTERMEDIATE UNIT CLOSE TO AN INTENSIVE CARE UNIT JUSTIFIED?. Critical Care Medicine. 7(3). 140–140. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact